Janus Living financials
$29.63−1.10%
Close Sep 30, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 27 | FY24 Dec 28 | FY23 Dec 30 | FY22 Dec 31 | FY21 Jan 1 | FY20 Jan 2 | FY19 Dec 28 |
|---|---|---|---|---|---|---|---|
| Revenue | $24.8M | $11.9M | $0.00 | $0.00 | $40.0M | $33.9M | $35.1M |
| Gross profit | $10.2M | $5.6M | $0.00 | $0.00 | $8.9M | $8.8M | $7.8M |
| Gross margin | 41.0% | 47.5% | — | — | 22.2% | 26.1% | 22.2% |
| Operating income | -$22.9M | -$6.9M | -$19.8M | -$1.2M | -$5.2M | -$8.6M | -$11.7M |
| Net income | -$344.5M | -$7.6M | -$7.8M | $11.0M | -$16.9M | -$8.5M | -$12.0M |
| Net margin | −1386.9% | −63.7% | — | — | −42.2% | −25.1% | −34.1% |
| Diluted EPS | $-5.91 | $-0.68 | $-1.95 | $3.49 | $-6.35 | $-4.59 | $-6.78 |
| EBITDA | -$19.5M | -$5.6M | -$3.3M | -$3.1M | $971.0K | -$4.9M | -$8.4M |
| Operating cash flow | -$7.2M | $1.8M | $1.5M | -$3.1M | -$5.3M | -$617.0K | -$3.5M |
| Free cash flow | -$7.2M | $1.8M | $1.5M | -$3.1M | -$7.0M | -$1.1M | -$3.7M |
| Diluted shares | 58.3M | 11.2M | 4.0M | 3.2M | 2.7M | 1.9M | 1.8M |
Balance sheet
| Period end | Dec 27 | Dec 28 | Dec 30 | Dec 31 | Jan 1 | Jan 2 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.2M | $7.2M | $5.0K | $61.0K | $705.0K | $379.0K |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $15.3M | $12.4M | $707.0K | $274.0K | $1.9M | $3.0M |
| Total assets | $1.22B | $75.7M | $18.5M | $46.8M | $15.2M | $24.4M |
| Total liabilities | $60.3M | $55.8M | $7.3M | $29.9M | $23.8M | $22.0M |
| Shareholders' equity | $1.16B | $20.0M | -$3.3M | $2.3M | -$8.7M | $2.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology